Innoviva Total Liabilities 2011-2026 | INVA

Annual Total Liabilities Innoviva

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	383 M	389 M	610 M	732 M	767 M	745 M	382 M	214 M	346 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
767 M	214 M	507 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
Aquestive Therapeutics AQST	194 M	$ 4.12	-0.36 %	$ 441 M	USA
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Arcturus Therapeutics Holdings ARCT	57.2 M	$ 8.32	3.67 %	$ 228 M	Israel
Arcutis Biotherapeutics ARQT	243 M	$ 23.65	0.08 %	$ 3.01 B	USA
BioVie BIVI	2.55 M	$ 1.46	2.82 %	$ 2.16 M	USA
BioLineRx Ltd. BLRX	25.4 M	$ 2.32	4.98 %	$ 908 M	Israel
BioNTech SE BNTX	2.76 B	$ 91.44	0.29 %	$ 27.2 B	Germany
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
BioXcel Therapeutics BTAI	140 M	$ 1.16	-2.12 %	$ 14.2 M	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Burford Capital Limited BUR	1.45 B	$ 4.52	9.18 %	$ 683 M	Britain
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Cabaletta Bio CABA	53 M	$ 3.1	4.56 %	$ 311 M	USA
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 3.17	1.44 %	$ 6.9 B	Israel
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Catalyst Biosciences CBIO	23.8 M	$ 19.48	0.39 %	$ 1.74 B	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Codexis CDXS	97.3 M	$ 1.95	6.87 %	$ 170 M	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	7.24 M	-	10.36 %	$ 9.8 M	USA
Anavex Life Sciences Corp. AVXL	8.95 M	$ 3.01	0.67 %	$ 257 M	USA
Cerus Corporation CERS	157 M	$ 1.91	2.69 %	$ 364 M	USA
Cullinan Management CGEM	39.6 M	$ 15.11	4.71 %	$ 910 M	USA
Coherus BioSciences CHRS	197 M	$ 1.72	-0.87 %	$ 201 M	USA
CollPlant Biotechnologies Ltd. CLGN	5.24 M	$ 0.46	-13.02 %	$ 5.27 M	Israel
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
CNS Pharmaceuticals CNSP	4.1 M	$ 2.25	-0.44 %	$ 998 K	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
Catalyst Pharmaceuticals CPRX	150 M	$ 24.95	1.05 %	$ 3.05 B	USA
Celldex Therapeutics CLDX	55.8 M	$ 31.33	0.85 %	$ 2.08 B	USA
Corbus Pharmaceuticals Holdings CRBP	20.7 M	$ 10.27	0.98 %	$ 137 M	USA
Cardiff Oncology CRDF	16.5 M	$ 1.6	1.27 %	$ 107 M	USA
Avenue Therapeutics ATXI	1.1 M	-	-52.27 %	$ 4.45 M	USA